Hims & Hers Health, Inc. HIMS has emerged as a transformative player in the personalized healthcare market, showcasing robust growth in 2024. Shares of the company have risen 43% in the past month, significantly...
LifeMD, Inc.’s LFMD Rex MD has launched TestoRx, a direct-to-consumer hormone therapy telehealth service. TestoRx provides an initial consultation with blood tests to pre-screen patients, offering both...
LifeMD, Inc. to Present at the June 1st Virtual Investor Summit
New York, New York--(Newsfile Corp. - May 23, 2023) - LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the virtual...